Loading EXCELINDUS price...
Peers are the listed companies in the exchange's own industry group: Specialty Chemicals. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
Latest quarterIn the quarter to June 2026 (results filed 13 Aug 2026), sales was Rs 294 cr and profit was Rs 29.5 cr.
Nothing in the filings we hold crosses one of our rules yet. Each rule needs a few complete years of results, so recently listed companies often show nothing here.
Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.
Over the last 17 results, the share rose on 5 and fell on 12, and moved by 3% or more on 14.
Q1 FY27: results filed 13 Aug 2026. The share went from its close on 12 Aug 2026 to its close on 14 Aug 2026 -3.55%.
Of every Rs 100 of sales in FY24, Rs 97 went on running costs, Rs 3.9 on depreciation, Rs 0.2 on interest and Rs 0.7 on tax; Rs 2.1 was left as profit.
Thin bar: money in (sales plus other income). Thick bar: where it went. Each year is scaled to its own sales, so the bars compare shares, not size.
| Measure | FY23 | FY24 | FY26 |
|---|---|---|---|
| Operating marginProfit from operations, before depreciation, interest and tax, per Rs 100 of sales. | 11.6% | 2.9% | - |
| Net marginProfit after everything, per Rs 100 of sales. | 7.3% | 2.1% | - |
| ROEProfit as a percentage of shareholders' money (from the March balance sheet). | 6.4% | 1.2% | - |
| ROCEOperating profit as a percentage of all long-term capital, owners' and lenders'. | 7.9% | 1.5% | 5.3% |
| Debt to equityBorrowings divided by shareholders' money. Lower is safer. | 0.00x | 0.00x | 0.00x |
| Interest coverHow many times operating profit covers the interest bill. Higher is safer. | 49.1x | 13.1x | - |
Each row is coloured against this company's own usual level, not against other companies: green is better than its middle year, red worse, plain is close to it. ROE, ROCE and debt rows start once the filings carry a full balance sheet (FY22 at the earliest).
At FY26 it owned Rs 2,105 Cr of assets. Its owners funded 81% of that and borrowings 0%.
From the March balance sheet in the company's annual filing (2026-03-31). Each bar is the full balance sheet; "everything else" is what the filed total leaves after the named lines.
In FY26 the business itself brought in Rs 53 Cr, spent Rs 79 Cr on plant and equipment, and cash rose by Rs 1 Cr over the year.
Rs 100 or more means every rupee of reported profit arrived as cash.
Full financial year to 2026-03-31, from the company's cash flow statement.
Median rather than average, so one loss-making or one very expensive peer cannot drag the reference. Valuation is shown without a colour verdict: a higher multiple can mean expensive, or faster growth expected, and only you can decide which.
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| PIDILITIND Pidilite Industries Limited | 1.51 L cr | 57.3x | 14.0x | 24.2% | 28.5% | 0.01 | 17.4% | +21.3% | 1.01% |
| SRF SRF Limited | 68,473 cr | 30.0x | 4.5x | 14.9% | - | 0.34 | 12.5% | +34.7% | 0.39% |
| FLUOROCHEM Gujarat Fluorochemicals Limited | 46,597 cr | 76.1x | 5.9x | 7.7% | 10.2% | 0.28 | 11.5% | +24.0% | 0.07% |
| NAVINFLUOR Navin Fluorine International Limited | 39,339 cr | 49.8x | 9.9x | 19.9% | 18.7% | 0.31 | 21.7% | +44.1% | 0.17% |
| DEEPAKNTR Deepak Nitrite Limited | 19,734 cr | 25.2x | 3.4x | 13.3% | 10.8% | 0.26 | 9.1% | +36.4% | 0.52% |
| AETHER Aether Industries Limited | 18,748 cr | 79.5x | 7.6x | 9.6% | 12.2% | 0.18 | 19.2% | +52.4% | 0.00% |
| ATUL Atul Limited | 16,416 cr | 21.3x | 2.5x | 11.8% | - | 0.02 | 11.3% | +20.9% | 0.45% |
| AARTIIND Aarti Industries Limited | 15,508 cr | 29.3x | 2.6x | 8.9% | 8.5% | 0.83 | 5.9% | +42.5% | 0.23% |
| FINEORG Fine Organic Industries Limited | 15,483 cr | 35.3x | 5.8x | 16.4% | 20.2% | 0.02 | 17.7% | +18.0% | 0.22% |
| BASF BASF India Limited | 13,290 cr | 20.6x | 3.4x | 16.3% | 13.1% | 0.00 | 4.0% | +24.5% | 0.65% |
| PRIVISCL Privi Speciality Chemicals Limited | 12,696 cr | 47.8x | 9.0x | 23.7% | 25.1% | 0.70 | 12.8% | +19.2% | 0.15% |
| ANURAS Anupam Rasayan India Limited | 12,542 cr | 71.6x | 3.8x | 4.9% | 7.5% | 0.39 | 8.9% | +34.8% | 0.12% |
| VINATIORGA Vinati Organics Limited | 11,105 cr | 24.8x | 3.5x | 14.2% | 17.7% | 0.00 | 18.8% | +28.4% | 0.70% |
| SUDEEPPHRM Sudeep Pharma Limited | 10,913 cr | 58.7x | 12.3x | 20.4% | 24.2% | 0.17 | 27.2% | - | 0.00% |
| JUBLINGREA Jubilant Ingrevia Limited | 9,516 cr | 31.0x | 3.0x | 9.9% | 10.8% | 0.25 | 6.6% | +25.3% | 0.83% |
| ALKYLAMINE Alkyl Amines Chemicals Limited | 8,362 cr | 37.2x | 5.5x | 14.7% | 14.6% | 0.00 | 13.6% | +30.2% | 0.61% |
| GALAXYSURF Galaxy Surfactants Limited | 7,876 cr | 22.3x | 2.9x | 12.9% | 12.7% | 0.06 | 6.2% | +39.4% | 0.27% |
| CLEAN Clean Science and Technology Limited | 7,583 cr | 32.6x | 4.8x | 14.7% | 19.2% | 0.00 | 23.7% | +10.5% | 0.84% |
| NEOGEN Neogen Chemicals Limited | 5,952 cr | 163.6x | 7.3x | 4.4% | 6.8% | 1.63 | 3.8% | +34.0% | 0.04% |
| BALAMINES Balaji Amines Limited | 5,923 cr | 28.9x | 3.0x | 9.8% | 10.2% | 0.06 | 13.8% | +27.2% | 0.60% |
| ACI Archean Chemical Industries Limited | 5,907 cr | 60.7x | 3.0x | 5.0% | 7.8% | 0.24 | 8.6% | +11.9% | 0.63% |
| FOSECOIND Foseco India Limited | 4,312 cr | 42.9x | 4.0x | 9.4% | - | 0.00 | 13.2% | +47.2% | 0.37% |
| LXCHEM Laxmi Organic Industries Limited | 4,171 cr | 33.2x | 2.1x | 6.3% | 4.4% | 0.27 | 4.0% | +39.8% | 0.33% |
| YASHO Yasho Industries Limited | 4,013 cr | 69.6x | 9.0x | 13.0% | 11.3% | 1.22 | 6.1% | +54.9% | 0.02% |
| EPIGRAL Epigral Limited | 3,861 cr | 14.3x | 1.7x | 12.2% | 14.8% | 0.25 | 10.3% | +16.3% | 0.47% |
| VISHNU Vishnu Chemicals Limited | 3,812 cr | 25.4x | 3.6x | 13.9% | 16.2% | 0.49 | 8.8% | +24.9% | 0.05% |
| TATVA Tatva Chintan Pharma Chem Limited | 3,671 cr | 71.4x | 4.7x | 6.6% | 7.6% | 0.15 | 9.2% | +43.0% | 0.06% |
| STYRENIX Styrenix Performance Materials Limited | 3,407 cr | 12.5x | 2.5x | 20.0% | 12.8% | 0.23 | 7.8% | +7.1% | 2.77% |
| CHEMPLASTS Chemplast Sanmar Limited | 2,896 cr | - | 1.6x | -22.3% | -4.1% | 1.11 | -9.2% | +2.3% | 0.00% |
| JUBLCPL Jubilant Agri and Consumer Products Limited | 2,762 cr | 21.6x | 6.0x | 28.2% | 34.9% | 0.06 | 6.6% | +18.4% | 0.00% |
| DDEVPLSTIK Ddev Plastiks Industries Limited | 2,511 cr | 11.8x | 2.5x | 21.1% | 28.9% | 0.05 | 6.7% | +28.6% | 0.93% |
| NOCIL NOCIL Limited | 2,457 cr | 37.3x | 1.4x | 3.7% | 4.1% | 0.00 | 4.8% | +19.9% | 1.38% |
| ROSSARI Rossari Biotech Limited | 2,297 cr | 15.3x | 1.7x | 11.3% | 15.3% | 0.31 | 5.9% | +28.2% | 0.12% |
| OAL Oriental Aromatics Limited | 1,943 cr | 595.3x | 2.9x | 0.8% | 6.2% | 0.61 | 0.5% | +15.2% | 0.09% |
| SHK S H Kelkar and Company Limited | 1,737 cr | 19.5x | 1.3x | 6.5% | 9.6% | 0.62 | 3.6% | +14.1% | 1.59% |
| VIDHIING Vidhi Specialty Food Ingredients Limited | 1,591 cr | 29.9x | 4.8x | 16.2% | 20.9% | 0.18 | 12.1% | +66.4% | 1.41% |
| CAMLINFINE Camlin Fine Sciences Limited | 1,547 cr | 366.1x | 1.5x | 0.1% | 2.9% | 0.67 | 0.0% | +22.7% | 0.00% |
| PAUSHAKLTD Paushak Limited | 1,531 cr | - | 3.1x | - | 8.7% | 0.16 | - | - | 0.40% |
| PLATIND Platinum Industries Limited | 1,234 cr | 24.5x | 2.8x | 10.8% | 14.9% | 0.01 | 11.1% | -5.6% | 0.00% |
| EXCELINDUS Excel Industries Limited | 1,052 cr | 14.7x | 0.6x | 4.2% | 5.3% | 0.00 | 6.6% | - | 1.64% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Operating margin has gone from 11.6% to 2.9% over these years - the share of every rupee of sales kept after running costs, before interest and tax. Full financial years only, so a part-year is never shown as a whole one. Hover any year for its complete figures.
2026 has paid Rs 13.75 per share, about Rs 1,627 on Rs 1 lakh at today's price. Dividends are at the company's discretion and can be cut or skipped.
| Date | Party | Side | Qty | Price | Value |
|---|---|---|---|---|---|
| 2026-08-19 | NK SECURITIES RESEARCH PRIVATE LIMITED | SELL | 64,341 | 1,113.23 | Rs 7.16 Cr |
| 2026-08-19 | NK SECURITIES RESEARCH PRIVATE LIMITED | BUY | 64,341 | 1,112.42 | Rs 7.16 Cr |
The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Insider trading data unavailable.
Announcements unavailable.
Backtest an equity strategy on real market data, free - no card needed.
Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.